Last reviewed · How we verify
NCT07408882: ADMIT
Evaluation of an Integrated Home Care Model
NA trial testing ADMIT integrated care Program in Older Adults (70 or More) Living at Home With Health and Social Complexity in 1,000 participants. Currently enrolling.
31 October 2026
Quick facts
| Lead sponsor | Parc Sanitari Pere Virgili |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 1,000 |
| Start date | 15 May 2025 |
| Primary completion | 31 October 2026 |
| Estimated completion | 31 October 2026 |
| Sites | 8 locations across Spain |
Drugs / interventions tested
- ADMIT integrated care Program
Conditions studied
- Older Adults (70 or More) Living at Home With Health and Social Complexity — all drugs for Older Adults (70 or More) Living at Home With Health and Social Complexity →
Sponsor
Parc Sanitari Pere Virgili — full company profile →
Who can join
70 and older, any sex, with Older Adults (70 or More) Living at Home With Health and Social Complexity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The demographic shift towards a progressive aging of the population represents an unprecedented challenge for Western societies and for the sustainability of health and social systems. Hypotheses: A complex, multi-component intervention based on integrated home care, facilitated by technological tools and focused on the frail person with complex needs (ADMIT Program): * Will increase at least 5% of the days spent at home compared to usual care * Will reduce exacerbations or health or social crisis at home * Will improve the quality of life and well-being of users and their informal caregiver * Will improve the experience of the people cared for, their caregivers and professionals in the health and social systems Main objective: To evaluate the effectiveness of the ADMIT program in increasing the % of days at home of frail elderly people compared to usual practice. Secondary objectives: To evaluate the effectiveness of the ADMIT program compared to usual care to reduce exacerbations or situations of crisis that motivate emergency care or hospitalizations. To evaluate the incremental cost-utility ratio of the ADMIT program in relation to usual practice, exploring different time horizons and different scenarios of population scalability. To evaluate the experience of the people treated, their informal caregivers and professionals. To identify the determinants of change and contextual factors of the program implementation process Methodology: Hybrid evaluation model that allows evaluating the process, effectiveness, safety and cost-utility while implementing the intervention in real life. Mixed methods, typical of implementation science, will be used, with different stages: First stage: co-creation of the care model and the technological platform with the participation of users and professionals Second stage: evaluation of the process, results and experience through a pragmatic randomized controlled trial with a batched stepped wedge design and comparison with a parallel "external" control group, matched using propensity score techniques. Applicability and Relevance: The ADMIT program is aligned with the current trend and the shared interest of evolving towards integrated social and health care, keeping people with complex needs in their homes for as long as possible and with the best possible quality of life. The ADMIT project is an implementation project supported by the Catalan Health Department and the Integrated Care Agency. The technological platform that will be co-created and piloted is expected to be adopted by Catalan Health Department for its scaling up in the territory.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07408882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Parc Sanitari Pere Virgili trials
Trials by the same sponsor.
- NCT07207980 — Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP) · NA · not yet recruiting
- NCT06836167 — +AGIL Barcelona: Integrated Care for Community-Dwelling Frail Older Adults · NA · recruiting
- NCT04115215 — Pre-FRONTal Brain STability, Key for Action Against Disability in AGing · NA · unknown
- NCT03578991 — Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease · NA · completed
- NCT03991390 — Effectiveness of Balance Exercise Program for Stroke Patients With Pusher Syndrome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07408882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Parc Sanitari Pere Virgili
- Last refreshed: 18 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07408882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing